Expand NUVL Menu
NUVL MENU

NUVL Stock Summary and Trading Ideas (Nuvalent - Class A | NASDAQ:NUVL)

Charts for Today's Stock Price and Implied Volatility in Nuvalent - Class A

22-Apr-2026

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for NUVL by Theoretical Edge and Win Rates

Sentiment

News

Trading Statistics

Key Ratios

Nuvalent - Class A (NUVL) Frequently Asked Questions

What does Nuvalent - Class A do?

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of its operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

What symbol and exchange does Nuvalent - Class A shares trade?

Nuvalent - Class A trades on the NASDAQ stock market under the symbol NUVL.

What is Nuvalent - Class A stock price doing today?

As of April 22, 2026, NUVL stock price climbed to $108.85 with 562,851 million shares trading.

What is Nuvalent - Class A's Beta?

NUVL has a beta of 0.62, meaning it tends to be less sensitive to market movements. NUVL has a correlation of 0.09 to the broad based SPY ETF.

How much is Nuvalent - Class A worth?

NUVL has a market cap of $8.45 billion. This is considered a Mid Cap stock.

What is the highest and lowest price Nuvalent - Class A traded in the last 3 year period?

In the last 3 years, NUVL traded as high as $113.51 and as low as $33.03.

What are the top ETFs holding Nuvalent - Class A?

The top ETF exchange traded funds that NUVL belongs to (by Net Assets): VTI, VB, IWM, XBI, VBR.

Is Nuvalent - Class A (NUVL) a good investment?

NUVL has outperformed the market in the last year with a return of +52.5%, while the SPY ETF gained +36.3%. However, in the most recent history, NUVL shares have underperformed the stock market with its stock returning -2.8% in the last 3 month period and +3.6% for the last 2 week period, while SPY has returned +3.5% and +5.2%, respectively.

What are the support and resistance levels for Nuvalent - Class A (NUVL)?

NUVL support price is $104.72 and resistance is $109.54 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NUVL shares will trade within this expected range on the day.

Market Data Delayed 15 Minutes